CoChat
Sign Up
Cited by 304

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Regulation of the autophagy protein LC3 by phosphorylation

Cherra, Salvatore J., Kulich, Scott M., Uechi, Guy, Balasubramani, Manimalha, Mountzouris, John, Day, Billy W., Chu, Charleen T.·2010·Journal of Cell Biology
DOI 10.1083/jcb.201002108PMC PMC2928022
Open this paper in CoChat — free account

Abstract

Macroautophagy is a major catabolic pathway that impacts cell survival, differentiation, tumorigenesis, and neurodegeneration. Although bulk degradation sustains carbon sources during starvation, autophagy contributes to shrinkage of differentiated neuronal processes. Identification of autophagy-related genes has spurred rapid advances in understanding the recruitment of microtubule-associated protein 1 light chain 3 (LC3) in autophagy induction, although braking mechanisms remain less understood. Using mass spectrometry, we identified a direct protein kinase A (PKA) phosphorylation site on LC3 that regulates its participation in autophagy. Both metabolic (rapamycin) and pathological (MPP+) inducers of autophagy caused dephosphorylation of endogenous LC3. The pseudophosphorylated LC3 mutant showed reduced recruitment to autophagosomes, whereas the nonphosphorylatable mutant exhibited enhanced puncta formation. Finally, autophagy-dependent neurite shortening induced by expression of a Parkinson disease–associated G2019S mutation in leucine-rich repeat kinase 2 was inhibited by dibutyryl–cyclic adenosine monophosphate, cytoplasmic expression of the PKA catalytic subunit, or the LC3 phosphorylation mimic. These data demonstrate a role for phosphorylation in regulating LC3 activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.201002108

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. PKA signaling reduces neurite injury and autophagy. (a–d) Mouse cortical neurons coexpressing GFP or GFP-PKA and LRRK2 G2019S or vector 7 d after transfection. (b) Quantification of neurite lengths. *, P = 0.001 versus empty vector/GFP; **, P = 0.007 versus LRRK2 G2019S/GFP (n = 50–60 cells/condition). (c) Quantification of branch points. *, P = 0.001 versus empty vector/GFP; **, P = 0.015 versus LRRK2 G2019S/GFP (n = 50–60 cells/condition). (d) Quantification of soma area (n = 50–60 cells/condition). (e, f, and h) SH-SY5Y neurites expressing GFP-LC3 48 h after transfection with/without cAMP for 24 h. (f) Quantification of neurite lengths. *, P = 1.48 × 10−5 versus empty vector/vehicle; **, P = 9.21 × 10−5 versus LRRK2 G2019S/vehicle (n = 80–90 cells/condition). (g) Quantification of neurite lengths from MPP+-treated SH-SY5Y cells with/without cAMP for 48 h. *, P = 0.0298 versus control/vehicle; **, P = 0.0166 versus MPP+/vehicle (n = 50–60 cells/condition). (h) Quantification of GFP-LC3–labeled puncta with/without cAMP for 24 h. *, P = 0.006 versus empty vector/vehicle; **, P = 6.58 × 10−4 versus LRRK2 G2019S/vehicle (n = 80–90 cells/condition). (i) Quantification of GFP-LC3 puncta from MPP+-treated SH-SY5Y cells with/without cAMP. *, P = 6.06 × 10−4 versus control/vehicle; **, P = 0.004 versus MPP+/vehicle (n = 50–55 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.
Figure 1. PKA signaling reduces neurite injury and autophagy. (a–d) Mouse cortical neurons coexpressing GFP or GFP-PKA and LRRK2 G2019S or vector 7 d after transfection. (b) Quantification of neurite lengths. *, P = 0.001 versus empty vector/GFP; **, P = 0.007 versus LRRK2 G2019S/GFP (n = 50–60 cells/condition). (c) Quantification of branch points. *, P = 0.001 versus empty vector/GFP; **, P = 0.015 versus LRRK2 G2019S/GFP (n = 50–60 cells/condition). (d) Quantification of soma area (n = 50–60 cells/condition). (e, f, and h) SH-SY5Y neurites expressing GFP-LC3 48 h after transfection with/without cAMP for 24 h. (f) Quantification of neurite lengths. *, P = 1.48 × 10−5 versus empty vector/vehicle; **, P = 9.21 × 10−5 versus LRRK2 G2019S/vehicle (n = 80–90 cells/condition). (g) Quantification of neurite lengths from MPP+-treated SH-SY5Y cells with/without cAMP for 48 h. *, P = 0.0298 versus control/vehicle; **, P = 0.0166 versus MPP+/vehicle (n = 50–60 cells/condition). (h) Quantification of GFP-LC3–labeled puncta with/without cAMP for 24 h. *, P = 0.006 versus empty vector/vehicle; **, P = 6.58 × 10−4 versus LRRK2 G2019S/vehicle (n = 80–90 cells/condition). (i) Quantification of GFP-LC3 puncta from MPP+-treated SH-SY5Y cells with/without cAMP. *, P = 6.06 × 10−4 versus control/vehicle; **, P = 0.004 versus MPP+/vehicle (n = 50–55 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.CC BY-NC-SA · PubMed Central
Figure 2. Cytoplasmic PKA inhibits autophagy. (a) RFP-GFP-LC3–labeled AVs in SH-SY5Y cells treated with rapamycin ± cAMP for 1 h. (b) Quantification of early AVs (GFP+ RFP+ puncta) in SH-SY5Y cells cotreated with rapamycin and cAMP for 3 h. *, P = 2.65 × 10−6 versus vehicle lacking rapamycin; **, P = 0.001 versus vehicle with rapamycin (n = 45–50 cells/condition). (c) Quantification of late AVs (RFP+-only puncta) in SH-SY5Y cells cotreated with rapamycin and cAMP for 3 h. *, P < 0.008 versus vehicle without rapamycin; **, P < 0.05 versus vehicle with rapamycin (n = 50–55 cells/condition). (d) LC3 immunoblot of SH-SY5Y cells treated with H89 or vehicle for 1 h. (e) Quantification of endogenous LC3-immunolabeled AVs in SH-SY5Y cells after 1-h treatment with rapamycin or DMSO (vehicle). *, P = 0.003 versus vehicle/GFP; **, P < 0.013 versus rapamycin/GFP (n = 35–45 cells/condition). (f) Quantification of endogenous LC3-immunolabeled AVs in SH-SY5Y cells 48 h after transfection. *, P = 3.52 × 10−4 versus empty vector/GFP group; **, P < 4.66 × 10−5 versus LRRK2 G2019S/GFP group (n = 80–90 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.
Figure 2. Cytoplasmic PKA inhibits autophagy. (a) RFP-GFP-LC3–labeled AVs in SH-SY5Y cells treated with rapamycin ± cAMP for 1 h. (b) Quantification of early AVs (GFP+ RFP+ puncta) in SH-SY5Y cells cotreated with rapamycin and cAMP for 3 h. *, P = 2.65 × 10−6 versus vehicle lacking rapamycin; **, P = 0.001 versus vehicle with rapamycin (n = 45–50 cells/condition). (c) Quantification of late AVs (RFP+-only puncta) in SH-SY5Y cells cotreated with rapamycin and cAMP for 3 h. *, P < 0.008 versus vehicle without rapamycin; **, P < 0.05 versus vehicle with rapamycin (n = 50–55 cells/condition). (d) LC3 immunoblot of SH-SY5Y cells treated with H89 or vehicle for 1 h. (e) Quantification of endogenous LC3-immunolabeled AVs in SH-SY5Y cells after 1-h treatment with rapamycin or DMSO (vehicle). *, P = 0.003 versus vehicle/GFP; **, P < 0.013 versus rapamycin/GFP (n = 35–45 cells/condition). (f) Quantification of endogenous LC3-immunolabeled AVs in SH-SY5Y cells 48 h after transfection. *, P = 3.52 × 10−4 versus empty vector/GFP group; **, P < 4.66 × 10−5 versus LRRK2 G2019S/GFP group (n = 80–90 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.CC BY-NC-SA · PubMed Central
Figure 3. PKA directly phosphorylates LC3. (a) 2D immunoblot probed for LC3 shows distinct species differing by isoelectric points. Forskolin increases abundance of species with a more acidic isoelectric point. (b) Metabolic labeling reveals greater 32P incorporation in HA-LC3 immunoprecipitated from forskolin-treated cells compared with control cells. Error bars indicate mean ± SEM. *, P < 0.05 versus vehicle; **, P < 0.05 versus forskolin (n = 3 independent experiments). (c) In vitro kinase assay with recombinant PKA and purified rat LC3. Phosphorylation was detected by autoradiography. Coomassie stain shows migration of the recombinant proteins. (d and e) Recombinant LC3 was incubated with ATP in the presence and absence of PKA. In the presence of PKA and ATP, the m/z 821.33 ion is lost with the appearance of an m/z 901.41 ion. (f) Mutation of the LC3 phosphorylation site to S12A abolishes PKA phosphorylation of LC3. (g) Immunoblot of cortical neurons treated with forskolin or DMSO (vehicle) probed with phospho-specific LC3 antibody, total LC3 antibody (LC3-nt), and lamin antibody as a loading control.
Figure 3. PKA directly phosphorylates LC3. (a) 2D immunoblot probed for LC3 shows distinct species differing by isoelectric points. Forskolin increases abundance of species with a more acidic isoelectric point. (b) Metabolic labeling reveals greater 32P incorporation in HA-LC3 immunoprecipitated from forskolin-treated cells compared with control cells. Error bars indicate mean ± SEM. *, P < 0.05 versus vehicle; **, P < 0.05 versus forskolin (n = 3 independent experiments). (c) In vitro kinase assay with recombinant PKA and purified rat LC3. Phosphorylation was detected by autoradiography. Coomassie stain shows migration of the recombinant proteins. (d and e) Recombinant LC3 was incubated with ATP in the presence and absence of PKA. In the presence of PKA and ATP, the m/z 821.33 ion is lost with the appearance of an m/z 901.41 ion. (f) Mutation of the LC3 phosphorylation site to S12A abolishes PKA phosphorylation of LC3. (g) Immunoblot of cortical neurons treated with forskolin or DMSO (vehicle) probed with phospho-specific LC3 antibody, total LC3 antibody (LC3-nt), and lamin antibody as a loading control.CC BY-NC-SA · PubMed Central
Figure 4. LC3 dephosphorylation is associated with enhanced recruitment to autophagosomes. (a and b) Immunoblots of SH-SY5Y cells treated with rapamycin for 1 h (a) or MPP+ for 24 h (b) were probed using the phospho-specific antibody, a C-terminal LC3 antibody (LC3), an N-terminal LC3 antibody (LC3-nt), and GAPDH as loading control. (c) Immunoblotting of SH-SY5Y cells expressing GFP-LC3–WT or –S12A reveals that a greater fraction of GFP-LC3–S12A migrates as LC3-II. (d) Quantification of GFP-LC3 puncta in SH-SY5Y cells expressing GFP-LC3–WT or –S12A. *, P = 0.023 versus WT neurite; **, P = 0.014 versus WT soma; ***, P = 0.003 versus WT total (n = 100–115 cells/condition). Error bars indicate mean ± SEM.
Figure 4. LC3 dephosphorylation is associated with enhanced recruitment to autophagosomes. (a and b) Immunoblots of SH-SY5Y cells treated with rapamycin for 1 h (a) or MPP+ for 24 h (b) were probed using the phospho-specific antibody, a C-terminal LC3 antibody (LC3), an N-terminal LC3 antibody (LC3-nt), and GAPDH as loading control. (c) Immunoblotting of SH-SY5Y cells expressing GFP-LC3–WT or –S12A reveals that a greater fraction of GFP-LC3–S12A migrates as LC3-II. (d) Quantification of GFP-LC3 puncta in SH-SY5Y cells expressing GFP-LC3–WT or –S12A. *, P = 0.023 versus WT neurite; **, P = 0.014 versus WT soma; ***, P = 0.003 versus WT total (n = 100–115 cells/condition). Error bars indicate mean ± SEM.CC BY-NC-SA · PubMed Central
Figure 5. LC3 phosphomimic shows reduced recruitment and suppresses neurite degeneration. (a and b) SH-SY5Y cells expressing GFP-LC3–WT or –S12D treated with rapamycin or vehicle for 1 h. Quantification of GFP-LC3 puncta. *, P = 2.31 × 10−8 versus vehicle/WT; **, P = 0.004 versus rapamycin/WT (n = 70–80 cells/condition). (c) Quantification of GFP-LC3 puncta in SH-SY5Y 48 h after transfection. *, P = 0.001 versus empty vector/GFP-LC3–WT; **, P = 0.025 versus LRRK2 G2019S/GFP-LC3–WT (n = 100–115 cells/condition). (d) Quantification of GFP-LC3 puncta in SH-SY5Y cells treated with MPP+ or vehicle for 48 h. *, P = 0.026 versus vehicle/WT; **, P = 0.043 versus MPP+/WT (n = 85–95 cells/condition). (e) Quantification of neurite lengths from SH-SY5Y cells 48 h after transfection. *, P = 6.37 × 10−4 versus empty vector/WT; **, P = 0.008 versus LRRK2 G2019S/WT (n = 100–115 cells/condition). (f) Quantification of neurite lengths from SH-SY5Y cells treated with MPP+ or vehicle for 48 h. *, P = 3.58 × 10−8 versus vehicle/WT; **, P = 3.74 × 10−4 versus MPP+/WT (n = 85–95 cells/condition). (g and h) Quantification of neurite length and branch points in cortical neurons coexpressing either GFP-LC3–WT or –S12A with empty vector or LRRK2 G2019S. *, P < 0.01 versus empty vector/WT; **, P < 0.036 versus LRRK2 G2019S/WT (n = 30–40 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.
Figure 5. LC3 phosphomimic shows reduced recruitment and suppresses neurite degeneration. (a and b) SH-SY5Y cells expressing GFP-LC3–WT or –S12D treated with rapamycin or vehicle for 1 h. Quantification of GFP-LC3 puncta. *, P = 2.31 × 10−8 versus vehicle/WT; **, P = 0.004 versus rapamycin/WT (n = 70–80 cells/condition). (c) Quantification of GFP-LC3 puncta in SH-SY5Y 48 h after transfection. *, P = 0.001 versus empty vector/GFP-LC3–WT; **, P = 0.025 versus LRRK2 G2019S/GFP-LC3–WT (n = 100–115 cells/condition). (d) Quantification of GFP-LC3 puncta in SH-SY5Y cells treated with MPP+ or vehicle for 48 h. *, P = 0.026 versus vehicle/WT; **, P = 0.043 versus MPP+/WT (n = 85–95 cells/condition). (e) Quantification of neurite lengths from SH-SY5Y cells 48 h after transfection. *, P = 6.37 × 10−4 versus empty vector/WT; **, P = 0.008 versus LRRK2 G2019S/WT (n = 100–115 cells/condition). (f) Quantification of neurite lengths from SH-SY5Y cells treated with MPP+ or vehicle for 48 h. *, P = 3.58 × 10−8 versus vehicle/WT; **, P = 3.74 × 10−4 versus MPP+/WT (n = 85–95 cells/condition). (g and h) Quantification of neurite length and branch points in cortical neurons coexpressing either GFP-LC3–WT or –S12A with empty vector or LRRK2 G2019S. *, P < 0.01 versus empty vector/WT; **, P < 0.036 versus LRRK2 G2019S/WT (n = 30–40 cells/condition). Error bars indicate mean ± SEM. Bars, 20 µm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 23

  1. Bok, 2003, An extranuclear locus of cAMP-dependent protein kinase action is necessary and sufficient for promotion of spiral ganglion neuronal survival by cAMP, J. Neurosci., 23, 777, 10.1523/JNEUROSCI.23-03-00777.2003 · DOI
  2. Boland, 2006, Neuronal macroautophagy: from development to degeneration, Mol. Aspects Med., 27, 503, 10.1016/j.mam.2006.08.009 · DOI
  3. Budovskaya, 2004, The Ras/cAMP-dependent protein kinase signaling pathway regulates an early step of the autophagy process in Saccharomyces cerevisiae, J. Biol. Chem., 279, 20663, 10.1074/jbc.M400272200 · DOI
  4. Budovskaya, 2005, An evolutionary proteomics approach identifies substrates of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA., 102, 13933, 10.1073/pnas.0501046102 · DOI
  5. Chalovich, 2006, Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells, J. Biol. Chem., 281, 17870, 10.1074/jbc.M602632200 · DOI
  6. Chu, 2009, Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models, Methods Enzymol., 453, 217, 10.1016/S0076-6879(08)04011-1 · DOI · Paper page
  7. Cuervo, 2004, Autophagy: in sickness and in health, Trends Cell Biol., 14, 70, 10.1016/j.tcb.2003.12.002 · DOI
  8. Holen, 1996, Role of cAMP in the regulation of hepatocytic autophagy, Eur. J. Biochem., 236, 163, 10.1111/j.1432-1033.1996.00163.x · DOI
  9. Jaeger, 2009, All-you-can-eat: autophagy in neurodegeneration and neuroprotection, Mol. Neurodegener., 4, 16, 10.1186/1750-1326-4-16 · DOI
  10. Klionsky, 2008, Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy., 4, 151, 10.4161/auto.5338 · DOI · Paper page
  11. Kouno, 2005, Solution structure of microtubule-associated protein light chain 3 and identification of its functional subdomains, J. Biol. Chem., 280, 24610, 10.1074/jbc.M413565200 · DOI
  12. MacLeod, 2006, The familial parkinsonism gene LRRK2 regulates neurite process morphology, Neuron., 52, 587, 10.1016/j.neuron.2006.10.008 · DOI
  13. Plowey, 2008, Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells, J. Neurochem., 105, 1048, 10.1111/j.1471-4159.2008.05217.x · DOI
  14. Scarlatti, 2008, Role of non-canonical beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells, Cell Death Differ., 15, 1318, 10.1038/cdd.2008.51 · DOI · Paper page
  15. Shevchenko, 2006, In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat. Protoc., 1, 2856, 10.1038/nprot.2006.468 · DOI
  16. Stephan, 2009, The Tor and PKA signaling pathways independently target the Atg1/Atg13 protein kinase complex to control autophagy, Proc. Natl. Acad. Sci. USA., 106, 17049, 10.1073/pnas.0903316106 · DOI
  17. Sugawara, 2004, The crystal structure of microtubule-associated protein light chain 3, a mammalian homologue of Saccharomyces cerevisiae Atg8, Genes Cells., 9, 611, 10.1111/j.1356-9597.2004.00750.x · DOI · Paper page
  18. Yamada, 2007, The crystal structure of Atg3, an autophagy-related ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation, J. Biol. Chem., 282, 8036, 10.1074/jbc.M611473200 · DOI
  19. Yang, 2007, Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons, Eur. J. Neurosci., 26, 2979, 10.1111/j.1460-9568.2007.05914.x · DOI
  20. Yorimitsu, 2007, Protein kinase A and Sch9 cooperatively regulate induction of autophagy in Saccharomyces cerevisiae, Mol. Biol. Cell., 18, 4180, 10.1091/mbc.E07-05-0485 · DOI
  21. Yue, 2009, The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases, Biochim. Biophys. Acta., 1793, 1496, 10.1016/j.bbamcr.2009.01.016 · DOI
  22. Zhang, 2007, Small molecule regulators of autophagy identified by an image-based high-throughput screen, Proc. Natl. Acad. Sci. USA., 104, 19023, 10.1073/pnas.0709695104 · DOI
  23. Zhu, 2007, Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death, Am. J. Pathol., 170, 75, 10.2353/ajpath.2007.060524 · DOI

Cited by

Sorted by citations

Metadata

Authors
Cherra, S. J., Kulich, S. M., Uechi, G., Balasubramani, M., Mountzouris, J., Day, B. W., & Chu, C. T.
Affiliations
  • Department of Pathology 1 , 2 , 3 , and 4
  • Abgent Inc., San Diego, CA 92121 6
Venue
Journal of Cell Biology
Publisher
Rockefeller University Press
Published
2010-08-16
Volume
190
Issue
4
Pages
533-539
ISSN
  • 1540-8140
  • 0021-9525
DOI
10.1083/jcb.201002108
PMC
PMC2928022
Cited by
304
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review